生物共振技术对过敏性疾病患者的检测和疗效观察  

The Clinical Study of BICOM Allergy Therapy

作　　者：曹俊[1] 孙洁[1] 张琼[1] 何晓[1] 周小勇[1] 

机构地区：[1]武汉市第一医院皮肤科,湖北武汉430022

出　　处：《中国医学文摘（皮肤科学）》2009年第3期142-143,共2页China Medical Abstracts(Dermatology)

摘　　要：目的观察生物共振技术检测过敏原的准确率及对过敏性皮肤病进行脱敏治疗的临床疗效。方法288例过敏性皮肤病患者中男156例,女132例;年龄4～68岁,平均36.6岁;病程0.5～20年,平均1.6年。其中荨麻疹198例,湿疹42例,异位性皮炎28例,过敏性鼻炎20例。采用生物共振技术对其进行了过敏原检测和脱敏治疗。结果288例过敏性皮肤病患者的过敏原阳性率为92.2%;脱敏治疗的治愈率为45.1%,有效率为70.5%。结论生物共振技术对于过敏性皮肤病的检测和治疗有一定作用。Objective To determine the accuracy of anaphylactogen detection and the clinical efficacy of bicom-bioresonnace therapy in patients with anaphylactic disease. Methods 288 patients with anaphylactic disease were collected from outpatients of Dermatology from April 2005 to August 2008. Of them,156 were males,and 132 were females,ranging in age from 4 to 68 years(a mean age of 36.6 years ),with duration of disease varying from 6 months to 20 year(mean course 1.6 years). Among these patients,urticaria accouted for 68.75%(198),eczema 14.58%(42),atopic dermatitis9.72%(28),and allergic rhinitis 6.94%(20). Anaphylactogen were detected and these patients were treated with bicom-bioresonnace therapy. Results The positive resultof the detection anaphylactogen was 92.2%. 70.5% of patients improved after bicom-bioresonnace therapy,and 45.1% of the cases were treated successfully. Conclusion Bicom-bioresonnace therapy may play a role in detecting anaphylactogen and treating patients with anaphylactic disease.

关 键 词：生物共振系统 过敏原 脱敏治疗 

分 类 号：R758.24[医药卫生—皮肤病学与性病学] R593.2[医药卫生—临床医学]